Haemonetics Corporation updated revenue guidance for the fiscal year 2024. For the year, the company expects GAAP total reported revenue growth to be between 10% to 12% against previous guidance of total reported revenue growth to be between 8% to 10% and total organic revenue growth to be between 10% to 12% against previous guidance of total organic revenue growth to be between 8% to 10%.